Medicine App Development in India: Medkart Consolidates Efforts to Create Intelligent, Generic Medicine Platform
In the heart of India's bustling healthcare system, a tech-enabled platform named Medkart is making waves. The goal? To bridge the gaps in access, trust, and affordability, particularly for chronic disease patients who often bear the brunt of high medicine costs.
Medkart's innovative approach is threefold. Firstly, it offers a price-comparison tool for generic medicines, allowing users to compare prices and compositions instantly. This transparency can lead to savings of up to 85-86% compared to branded equivalents, a significant relief for patients grappling with high monthly drug costs.
Secondly, Medkart focuses on "Medkart Assured" generics, ensuring quality and safety by sourcing from audited manufacturing plants and adhering to Schedule M compliance. This move addresses longstanding doubts about generic medicines and builds trust among users.
Thirdly, Medkart's hybrid model combines 100+ retail stores with online ordering and delivery coverage across 35,000+ pin codes, including Tier-2 and rural areas. This reduces the need for patients to travel long distances to find affordable medicines locally.
The platform also caters to non-tech-savvy and older patients by integrating WhatsApp for ordering and featuring prescription upload and matching. Furthermore, it offers targeted support for chronic conditions like diabetes, hypertension, kidney, and heart diseases, helping patients find relevant generics quickly and affordably.
Lastly, Medkart educates users about generic medicines, providing transparent information about ingredients, dosages, and side effects to build confidence in switching from branded drugs.
The National Health Accounts Estimates 2021-22 show a decrease in out-of-pocket expenditure from 62.6% in 2014-15, but it remains substantial. Chronic disease patients in tier-2 and rural areas often travel kilometers, pay for branded substitutes, and spend nearly 30% of their household income on drugs alone.
With its focus on affordability, trust, and access, Medkart is unlocking a new healthcare era for India, where savings don't have to mean sacrifice. The shift toward generics, supported by stricter manufacturing standards and better public awareness, is a promising step towards more equitable healthcare for all.
[1] Medkart Press Release, link [2] The Economic Times, "Medkart: Making Medicines Affordable in India", link [3] The Hindu, "Generic Medicine App Medkart Raises $10 M", link [4] Business Standard, "Medkart: A Tech-Enabled Solution for Affordable Medicines in India", link
Within this new healthcare era, Medkart's partnership with science ensures the provision of high-quality and safe generic medicines, aiming to revolutionize health-and-wellness for Indians. By embracing technology, this innovative platform offers insurance for millions, providing affordable access to essential medicines, even in technology-sparse regions.
